Geode Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Sell |
|
|||||
|
2025
Q1 | $7.29M | Buy |
|
|||||
|
2024
Q4 | $10.3M | Buy |
|
|||||
|
2024
Q3 | $13.1M | Buy |
|
|||||
|
2024
Q2 | $8.65M | Buy |
|
|||||
|
2024
Q1 | $12.5M | Buy |
|
|||||
|
2023
Q4 | $8.05M | Buy |
|
|||||
|
2023
Q3 | $4.96M | Buy |
|
|||||
|
2023
Q2 | $5.66M | Buy |
|
|||||
|
2023
Q1 | $1.75M | Buy |
|
|||||
|
2022
Q4 | $1.67M | Sell |
|
|||||
|
2022
Q3 | $909K | Sell |
|
|||||
|
2022
Q2 | $1.45M | Sell |
|
|||||
|
2022
Q1 | $3.09M | Sell |
|
|||||
|
2021
Q4 | $9.05M | Sell |
|
|||||
|
2021
Q3 | $13.6M | Buy |
|
|||||
|
2021
Q2 | $7.21M | Buy |
|
|||||
|
2021
Q1 | $8.24M | Buy |
|
|||||
|
2020
Q4 | $10.6M | Buy |
|
|||||
|
2020
Q3 | $3.49M | Buy |
|
|||||
|
2020
Q2 | $4.66M | Buy |
|